fda on tirzepatide Diabetes Drug - Gets Approval for Weight Loss Warning: Risks of Non-FDA Approved

This echoes the clinical practice already emerging with semaglutide and tirzepatide, where some prescribers step patients down after target weight is achieved

Your healthcare provider can help evaluate whether adjusting your dosage might help

Effective weight loss medication should be accessible to everyone who can benefit from it, not just those who can afford $1,000+ monthly costs or who have exceptional insurance coverage

Tastes pretty good too

If your injection day is Monday but you travel on Monday, injecting Tuesday instead shifts everything by one day, and the impact is minimal

Mean ages in the study were 46 among patients using semaglutide for obesity and 57 among those using it for diabetes